Advances in treatment have extended the life expectancy of patients with metastatic bone disease (MBD). Patients could experience more skeletal-related events (SREs) as a result of this progress. Those who have already experienced a SRE could encounter another local management for a subsequent SRE, which is not part of the treatment for the initial SRE. However, there is a noted gap in research on the rate and characteristics of subsequent SREs requiring further localized treatment, obligating clinicians to extrapolate from experiences with initial SREs when confronting subsequent ones. This study aimed to investigate the proportion of MBD patients developing subsequent SREs requiring local treatment, examine if there are prognostic differences at the initial treatment between those with single versus subsequent SREs, and determine if clinical, oncological, and prognostic features differ between initial and subsequent SRE treatments. This retrospective study included 3,814 adult patients who received local treatment – surgery and/or radiotherapy – for bone metastasis between 1 January 2010 and 31 December 2019. All included patients had at least one SRE requiring local treatment. A subsequent SRE was defined as a second SRE requiring local treatment. Clinical, oncological, and prognostic features were compared between single SREs and subsequent SREs using Mann-Whitney U test, Fisher’s exact test, and Kaplan–Meier curve.Aims
Methods
This study aimed to evaluate the effectiveness of the induced membrane technique for treating infected bone defects, and to explore the factors that might affect patient outcomes. A comprehensive search was performed in PubMed, Embase, and the Cochrane Central Register of Controlled Trials databases between 1 January 2000 and 31 October 2021. Studies with a minimum sample size of five patients with infected bone defects treated with the induced membrane technique were included. Factors associated with nonunion, infection recurrence, and additional procedures were identified using logistic regression analysis on individual patient data.Aims
Methods
Ageing-related incompetence becomes a major hurdle for the clinical translation of adult stem cells in the treatment of osteoarthritis (OA). This study aims to investigate the effect of stepwise preconditioning on cellular behaviours in human mesenchymal stem cells (hMSCs) from ageing patients, and to verify their therapeutic effect in an OA animal model. Mesenchymal stem cells (MSCs) were isolated from ageing patients and preconditioned with chondrogenic differentiation medium, followed by normal growth medium. Cellular assays including Bromodeoxyuridine / 5-bromo-2'-deoxyuridine (BrdU), quantitative polymerase chain reaction (q-PCR), β-Gal, Rosette forming, and histological staining were compared in the manipulated human mesenchymal stem cells (hM-MSCs) and their controls. The anterior cruciate ligament transection (ACLT) rabbit models were locally injected with two millions, four millions, or eight millions of hM-MSCs or phosphate-buffered saline (PBS). Osteoarthritis Research Society International (OARSI) scoring was performed to measure the pathological changes in the affected joints after staining. Micro-CT analysis was conducted to determine the microstructural changes in subchondral bone.Aims
Methods
We conducted a prospective, randomized study comparing the outcomes of total knee arthroplasty (TKA) respectively through a quadriceps-sparing (QS) approach and a MIS medial parapatellar (MP) approach at 2-year follow-up. Sixty patients (80 knees) with primary osteoarthritis were enrolled in this study. Patients were blinded to be treated with and randomized to be grouped by either MP group (40 knees) or QS group (40 knees). Thirty-seven MIS MP TKAs and thirty-eight QS TKAs completed the 2-year follow-up. According to the isokinetic study, the recovery of muscle strength (peak muscle torque) and normalization of muscle balance (H/Q peak-torque ratio) were comparable in both groups at either 2-month or 2-year follow-up. Tourniquet and surgical time in the QS group was significantly longer (approximately 20 minutes) than that in the MP group. The hip-knee-ankle axis measured after surgery was significantly more varus in the QS group than that in the MP group. The axis in both groups did not significantly progress at 2-year follow-up. There were no infections and no revisions at 2-year follow-up in both groups. More outlier cases (4 knees) were noted in the QS group when compared with the MP group (no outlier). However, no differences regarding the clinic outcomes (including VAS, HSS knee score, ROM and satisfaction) were observed between these two groups after either two months or two years upon operation. In both groups, there was a significant improvement of these parameters at 2-year follow-up in contrast with 2-month follow-up and pre-operative status. In this study, we conclude that MIS medial parapatellar TKAs could achieve comparable recovery of muscle strength, normalization of hamstring-quadriceps muscle balance and clinical outcomes when compared with QS TKAs; moreover it provides more reliable alignment and fewer complications than quadriceps-sparing TKAs.
